01 1BCN Peptides
01 1SALMON CALCITONIN
01 1Spain
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-12-21
Pay. Date : 2020-12-16
DMF Number : 19579
Submission : 2006-07-05
Status : Active
Type : II
20
Bcn Peptides Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SALMON CALCITONIN, with a corresponding US DMF Number 19579.
Remarkably, this DMF maintains an Active status since its submission on July 05, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 21, 2020, and payment made on December 16, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
